as on October 18, 2025 at 12:43 am IST
Day's Low
Day's High
2.01%
Downside
0.03%
Upside
52 Week's Low
52 Week's High
67.55%
Downside
0.84%
Upside
Check Ionis Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$11.5B
EPS (TTM)
-1.9167
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.44%
PE Ratio (TTM)
-19.95
Industry PE ratio
8.355964912280701
PEG Ratio
25.7033
EBITDA
-255.2M
Revenue (TTM)
944.0M
Profit Margin
-28.41%
Return On Equity TTM
34341100.00%
Track how Ionis Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Ionis Pharmaceuticals, Inc. in the last 5 years
Lowest (-163.66x)
March 31, 2022
Today (-19.95x)
October 17, 2025
Industry (8.36x)
October 17, 2025
Highest (-10.69x)
September 30, 2023
Today’s Price to Earnings Ratio: -19.95x
Compare market cap, revenue, PE, and other key metrics of Ionis Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $11.5B | 55.04% | -19.95 | -28.41% | |
BUY | $61.6B | 230.86% | -505.15 | -12.96% | |
NA | $35.8B | NA | NA | -3.89% | |
BUY | $104.6B | 87.37% | 29.01 | 31.86% | |
BUY | $61.1B | -5.1% | 14.53 | 31.37% |
The Ionis Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ionis Pharmaceuticals, Inc. investment value today
Current value as on today
₹1,96,652
Returns
₹96,652
(+96.65%)
Returns from Ionis Pharmaceuticals, Inc. Stock
₹91,738 (+91.74%)
Dollar Returns*
₹4,914 (+4.91%)
Based on 30 analysts
66.67%
Buy
23.33%
Hold
10.00%
Sell
Based on 30 analysts, 66.67% of analysts recommend a 'BUY' rating for Ionis Pharmaceuticals, Inc.. Average target price of $76.91
Get share price movements and forecasts by analysts on Ionis Pharmaceuticals, Inc..
What analysts predicted
4.04%UPSIDE
Target Price
$76.91
Current Price
$73.8
Analyzed by
30 Analysts
Target
$76.91
Ionis Pharmaceuticals, Inc. target price $76.91, a slight upside of 4.04% compared to current price of $73.8. According to 30 analysts rating.
Search interest for Ionis Pharmaceuticals, Inc. Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 08 October
Wed, 05:57 PM
-JPMorgan upgrades Ionis Pharmaceuticals to overweight, raising price target to $80, citing strong drug pipeline and potential for breakeven.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -146.93M → 123.55M (in $), with an average increase of 218.9% per quarter
Best in 1 Year
In the last 1 year, IONS has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
Revenue is up for the last 2 quarters, 131.61M → 452.04M (in $), with an average increase of 70.9% per quarter
Price Rise
In the last 3 months, IONS stock has moved up by 73.3%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 146.6% return, outperforming this stock by 89.5%
Organisation | Ionis Pharmaceuticals, Inc. |
Headquarters | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 |
Industry | Health Technology |
CEO | Dr. Brett P. Monia Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Kyle Jenne | Executive VP & Chief Global Product Strategy Officer |
Mr. Darren Gonzales | Chief Accounting Officer & Senior VP |
Dr. C. Frank Bennett BSc, Ph.D. | Executive VP & Chief Scientific Officer |
Ms. Tracy Berns J.D. | Senior VP and Chief Compliance & Quality Assurance Officer |
Dr. Brett P. Monia Ph.D. | Founder, CEO & Director |
Mr. Patrick R. O'Neil Esq. | Executive VP, Chief Legal Officer, General Counsel & Corporate Secretary |
Dr. Richard S. Geary Ph.D. | Executive VP & Chief Development Officer |
Mr. D. Wade Walke Ph.D. | Senior Vice President of Investor Relations |
Ms. Hayley Soffer | Vice President of Corporate Communications |
Ms. Elizabeth L. Hougen M.A., M.B.A., M.S. | Executive VP of Finance & CFO |
Ionis Pharmaceuticals, Inc. share price today is $73.8 as on . Ionis Pharmaceuticals, Inc. share today touched a day high of $73.82 and a low of $72.32.
Ionis Pharmaceuticals, Inc. share touched a 52 week high of $74.42 on and a 52 week low of $23.95 on . Ionis Pharmaceuticals, Inc. stock price today i.e. is trending at $73.8,which is 0.83% down from its 52 week high and 208.14% up from its 52 week low.
Ionis Pharmaceuticals, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Ionis Pharmaceuticals, Inc. (IONS) shares with as little as ₹88.054 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Ionis Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ionis Pharmaceuticals, Inc. share’s latest price of $73.8 as on October 18, 2025 at 12:43 am IST, you will get 0.1355 shares of Ionis Pharmaceuticals, Inc.. Learn more about
fractional shares .
Ionis Pharmaceuticals, Inc. stock has given 55.04% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?